| Full Name | Daniel Kunz |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 22 Years |
| Location | 7 Alumni Dr, Exeter, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760605356 | NPI | - | NPPES |
| 3075280 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 13460 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Exeter Hospital Inc | Exeter, NH | Hospital |
| Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
| York Hospital | York, ME | Hospital |
| Elliot Hospital | Manchester, NH | Hospital |
| Wentworth-douglass Hospital | Dover, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Core Physicians Llc | 2769563253 | 234 |
News Archive
The PhRMA Foundation has announced a shift in mission that will focus on building a better system of value assessment in U.S. health care – empowering patients and improving health outcomes and efficiencies – while helping shape a new era of multidisciplinary research and drug development, based strongly in the use of advanced technology and data.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed its exploratory Phase I clinical trial of RX-3117 in cancer patients.
University of Adelaide researchers have taken a step forward in unravelling the causes of a commonly inherited intellectual disability, finding that a genetic mutation leads to a reduction in certain proteins in the brain.
A study from Massachusetts General Hospital researchers finds that electronic consultations in allergy and immunology can simplify the process of providing the most appropriate care, often reducing the need for in-person specialist visits.
› Verified 8 days ago
| Entity Name | Core Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336330588 PECOS PAC ID: 2769563253 Enrollment ID: O20080123000205 |
News Archive
The PhRMA Foundation has announced a shift in mission that will focus on building a better system of value assessment in U.S. health care – empowering patients and improving health outcomes and efficiencies – while helping shape a new era of multidisciplinary research and drug development, based strongly in the use of advanced technology and data.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed its exploratory Phase I clinical trial of RX-3117 in cancer patients.
University of Adelaide researchers have taken a step forward in unravelling the causes of a commonly inherited intellectual disability, finding that a genetic mutation leads to a reduction in certain proteins in the brain.
A study from Massachusetts General Hospital researchers finds that electronic consultations in allergy and immunology can simplify the process of providing the most appropriate care, often reducing the need for in-person specialist visits.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Kunz, DO 7 Holland Way Fl 1, Exeter, NH 03833-2997 Ph: (603) 658-1306 | Daniel Kunz, DO 7 Alumni Dr, Exeter, NH 03833-2118 Ph: (603) 658-1306 |
News Archive
The PhRMA Foundation has announced a shift in mission that will focus on building a better system of value assessment in U.S. health care – empowering patients and improving health outcomes and efficiencies – while helping shape a new era of multidisciplinary research and drug development, based strongly in the use of advanced technology and data.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed its exploratory Phase I clinical trial of RX-3117 in cancer patients.
University of Adelaide researchers have taken a step forward in unravelling the causes of a commonly inherited intellectual disability, finding that a genetic mutation leads to a reduction in certain proteins in the brain.
A study from Massachusetts General Hospital researchers finds that electronic consultations in allergy and immunology can simplify the process of providing the most appropriate care, often reducing the need for in-person specialist visits.
› Verified 8 days ago
Dr. Sean T. Keesee, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5 Alumni Dr Fl 2, Exeter, NH 03833 Phone: 603-580-7525 Fax: 603-580-7542 | |
Bonnie H Couture, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3 Alumni Dr Ste 204, Exeter, NH 03833 Phone: 603-778-2899 | |
Hillary S Tompkins, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 201, Exeter, NH 03833 Phone: 603-772-5528 Fax: 603-777-1296 | |
Dr. Joshua Michael Krasnow, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 101, Exeter, NH 03833 Phone: 603-773-9992 Fax: 603-778-6393 | |
Dr. Gregory M Goodkin, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 101, Exeter, NH 03833 Phone: 603-773-9992 Fax: 603-778-6393 | |
Paul King Deranian, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 301, Exeter, NH 03833 Phone: 603-775-0234 Fax: 603-772-1188 | |
Isabella N Stumpf, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5 Alumni Dr, Exeter, NH 03833 Phone: 603-580-6457 Fax: 603-580-6428 |